February 13, 2023
Salix Announces 2023 Gastrointestinal Health Scholars Program
November 29, 2022
Bausch Health Canada Announce Arazlo (tazarotene) was Added to the Quebec Public Drug Plan for Treatment of Acne Vulgaris
No current content.
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people’s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.
In Canada, the company’s prescription product portfolio is focused on eye health, dermatology and cardio-metabolic conditions. More information can be found at the Company’s website at https://www.bauschhealth.ca.
February 13, 2023
November 29, 2022
No current content.